However, even if curcumin does not represent a new ligand for neither TREM2 or Siglec-3, these findings suggest the huge potential that could derive by controlling both TREM2 or Siglec-3 pathways involved in developing Alzheimer’s disease (Figure 3). Here, TREM2 is linked to early-onset autosomal dominant Alzheimer disease.